Johnson & Johnson Services Inc is the U.S. services arm of the large health care company Johnson & Johnson, which makes medicines and consumer health products. According to filings, it lobbies on health-related federal policies such as the 340B drug discount program, Medicare Part B and drug pricing, biosimilar laws, and average sales price (ASP) reporting and patient-safety issues. It uses Farragut Partners LLP as a lobby firm and reported about $200,000 in lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
EDWARD WHITFIELD
The latest disclosures for this client.
FARRAGUT PARTNERS LLP
Q2FARRAGUT PARTNERS LLP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FARRAGUT PARTNERS LLP
JEFF MACKINNON
FARRAGUT PARTNERS LLP
JEFFERY C. MORTIER
FARRAGUT PARTNERS LLP
JODY SHINTARO GALE
FARRAGUT PARTNERS LLP
KRISTEN BAUTZ
FARRAGUT PARTNERS LLP
mr DYLAN MOORE
FARRAGUT PARTNERS LLP
SARAH WALTER
FARRAGUT PARTNERS LLP
WILLIAM KRIEGER
FARRAGUT PARTNERS LLP
FARRAGUT PARTNERS LLP
Q4FARRAGUT PARTNERS LLP
Q3FARRAGUT PARTNERS LLP
Q2FARRAGUT PARTNERS LLP
Q1